Ovaa Shield DS Combipack is a combination pharmaceutical formulation containing Acetylcysteine 600 mg, Astaxanthin 4 mg, and Clomiphene 100 mg, designed to address specific clinical indications. Acetylcysteine acts as a mucolytic agent, facilitating the breakdown of mucus in respiratory conditions, and also serves as an antioxidant by replenishing intracellular glutathione levels. Astaxanthin, a potent carotenoid antioxidant, contributes to reducing oxidative stress and inflammation, thereby supporting cellular health and potentially enhancing reproductive function. Clomiphene, a selective estrogen receptor modulator (SERM), is primarily utilized to induce ovulation in anovulatory women, particularly in cases of infertility related to polycystic ovary syndrome (PCOS) or other ovulatory disorders. The synergistic combination in Ovaa Shield DS Combipack aims to improve reproductive outcomes by enhancing ovulatory function while mitigating oxidative damage that may impair fertility. This formulation is intended for use under medical supervision, with dosing and duration tailored to individual patient needs. Contraindications include hypersensitivity to any component, liver dysfunction, uncontrolled thyroid or adrenal disorders, and pregnancy. Common adverse effects may include gastrointestinal discomfort, visual disturbances, or ovarian hyperstimulation. Patient monitoring is advised to optimize therapeutic efficacy and minimize potential risks.